X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Pharma with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs FDC LTD. - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA FDC LTD. GSK PHARMA/
FDC LTD.
 
P/E (TTM) x 59.9 17.2 348.6% View Chart
P/BV x 11.7 3.6 328.0% View Chart
Dividend Yield % 2.1 1.3 158.9%  

Financials

 GSK PHARMA   FDC LTD.
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
FDC LTD.
Mar-14
GSK PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs3,850144 2,682.9%   
Low Rs2,96679 3,754.0%   
Sales per share (Unadj.) Rs332.347.6 698.7%  
Earnings per share (Unadj.) Rs44.37.6 582.2%  
Cash flow per share (Unadj.) Rs47.29.0 524.1%  
Dividends per share (Unadj.) Rs50.002.25 2,222.2%  
Dividend yield (eoy) %1.52.0 72.5%  
Book value per share (Unadj.) Rs202.747.5 426.5%  
Shares outstanding (eoy) m84.70177.83 47.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x10.32.3 438.4%   
Avg P/E ratio x76.914.6 526.2%  
P/CF ratio (eoy) x72.212.3 584.4%  
Price / Book Value ratio x16.82.3 718.2%  
Dividend payout %112.929.6 381.7%   
Avg Mkt Cap Rs m288,64319,784 1,459.0%   
No. of employees `0004.6NA-   
Total wages/salary Rs m4,4341,221 363.3%   
Avg. sales/employee Rs Th6,104.5NM-  
Avg. wages/employee Rs Th961.6NM-  
Avg. net profit/employee Rs Th813.7NM-  
INCOME DATA
Net Sales Rs m28,1488,459 332.8%  
Other income Rs m1,218394 309.6%   
Total revenues Rs m29,3668,852 331.7%   
Gross profit Rs m4,7742,070 230.6%  
Depreciation Rs m248249 99.6%   
Interest Rs m031 0.0%   
Profit before tax Rs m5,7442,184 263.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m260-   
Tax Rs m2,018606 333.3%   
Profit after tax Rs m3,7521,353 277.3%  
Gross profit margin %17.024.5 69.3%  
Effective tax rate %35.127.7 126.7%   
Net profit margin %13.316.0 83.3%  
BALANCE SHEET DATA
Current assets Rs m21,4624,355 492.8%   
Current liabilities Rs m10,5361,792 588.0%   
Net working cap to sales %38.830.3 128.1%  
Current ratio x2.02.4 83.8%  
Inventory Days Days6844 152.2%  
Debtors Days Days1625 66.6%  
Net fixed assets Rs m4,7173,025 155.9%   
Share capital Rs m847179 474.2%   
"Free" reserves Rs m16,3088,243 197.8%   
Net worth Rs m17,1718,453 203.1%   
Long term debt Rs m1611 149.5%   
Total assets Rs m30,62010,557 290.0%  
Interest coverage xNM71.4-  
Debt to equity ratio x00 73.6%  
Sales to assets ratio x0.90.8 114.7%   
Return on assets %12.313.1 93.5%  
Return on equity %21.916.0 136.5%  
Return on capital %33.623.5 142.8%  
Exports to sales %013.3 0.1%   
Imports to sales %15.13.3 450.2%   
Exports (fob) Rs m41,126 0.4%   
Imports (cif) Rs m4,237283 1,498.2%   
Fx inflow Rs m5191,146 45.3%   
Fx outflow Rs m8,320355 2,341.6%   
Net fx Rs m-7,801791 -986.4%   
CASH FLOW
From Operations Rs m1,3861,485 93.3%  
From Investments Rs m5,010-620 -808.7%  
From Financial Activity Rs m-6,383-753 848.3%  
Net Cashflow Rs m12113 10.5%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 4.7 217.0%  
FIIs % 23.8 7.5 317.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 19.0 81.1%  
Shareholders   102,036 23,730 430.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 21, 2017 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS